Literature DB >> 20111911

Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity.

Akiko Yoneda1, Toshiaki Sano, Shozo Yamada, Abdulkader Obari, Zhi Rong Qian, Elaine Lu Wang, Naoko Inosita, Eiji Kudo.   

Abstract

Growth hormone (GH)-producing pituitary adenomas have been classified into densely and sparsely granulated adenomas. The latter are chromophobic with weak GH-positivity and characteristically possess fibrous body (FB), aggregation of cytokeratin filaments. We report eight cases of unusual chromophobic adenomas. GH-immunoreactivity was detected in most adenoma cells in five cases and scattered in three cases. However, it appeared much weaker than that seen in ordinary GH-producing adenomas because of spotty immunoreactivity. Although intracytoplasmic organelles were well-developed, secretory granules were small and sparse. FB was not identified in any cases. Thyroid-stimulating hormone was positive in four cases. Pit-1 protein was positive in all eight cases. A weak labeling with GH probe was detected in two of two cases examined by in situ hybridization. Acromegalic features were evident in four cases, while mild or absent in four cases. GH levels were below 5 microg/l in four cases and 5-10 microg/l in the remaining cases. Macroadenomas and invasive adenomas were seen in seven and six cases, respectively.Pituitary adenomas that show a faint GH-immunoreactivity but lack FB do not fit the established classification. These adenomas may be a distinct pituitary adenoma type of Pit-1 lineage with endocrinologically low activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20111911     DOI: 10.1007/s12022-009-9105-z

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  23 in total

1.  Somatotropic adenomas without acromegaly.

Authors:  J Trouillas; G Sassolas; B Loras; B Velkeniers; M Raccurt; L Chotard; F Berthezène; J Tourniaire; C Girod
Journal:  Pathol Res Pract       Date:  1991-12       Impact factor: 3.250

2.  Histopathological analyses of silent pituitary somatotroph adenomas using immunohistochemistry, in situ hybridization and confocal laser scanning microscopic observation.

Authors:  A Matsuno; J Itoh; Y Itoh; R Y Osamura; H Katayama; T Nagashima
Journal:  Pathol Res Pract       Date:  2001       Impact factor: 3.250

3.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Expression of GATA-2 in human pituitary adenomas.

Authors:  Katsuya Umeoka; Naoko Sanno; R Yoshiyuki Osamura; Akira Teramoto
Journal:  Mod Pathol       Date:  2002-01       Impact factor: 7.842

5.  Clinically silent somatotropinomas may be biochemically active.

Authors:  Alla A Sakharova; Eleni V Dimaraki; William F Chandler; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2005-01-25       Impact factor: 5.958

6.  Morphological characterization and subtyping of silent somatotroph adenomas.

Authors:  H Naritaka; T Kameya; Y Sato; S Furuhata; M Otani; T Kawase
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

7.  Growth hormone and prolactin gene expression in human densely and sparsely granulated somatotroph adenomas by in situ hybridization with digoxigenin-labeled probes.

Authors:  S Yamada; M Takahashi; M Hara; T Sano; T Aiba; Y Shishiba; T Suzuki; S L Asa
Journal:  Diagn Mol Pathol       Date:  1994-03

8.  Apparently silent somatotroph adenomas.

Authors:  P Pagesy; J Y Li; M Kujas; F Peillon; O Delalande; A Visot; P Derome
Journal:  Pathol Res Pract       Date:  1991-12       Impact factor: 3.250

9.  Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.

Authors:  Abdulkader Obari; Toshiaki Sano; Kenichi Ohyama; Eiji Kudo; Zhi Rong Qian; Akiko Yoneda; Nasim Rayhan; Muhammad Mustafizur Rahman; Shozo Yamada
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

10.  Pathology of growth hormone-producing tumors of the human pituitary.

Authors:  K Kovacs; E Horvath
Journal:  Semin Diagn Pathol       Date:  1986-02       Impact factor: 3.464

View more
  3 in total

1.  Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly.

Authors:  Amy A Swanson; Dana Erickson; Diane Mary Donegan; Sarah M Jenkins; Jamie J Van Gompel; John L D Atkinson; Bradley J Erickson; Caterina Giannini
Journal:  Pituitary       Date:  2020-10-19       Impact factor: 4.107

2.  Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas.

Authors:  Hiroshi Nishioka; Naoko Inoshita; Toshiaki Sano; Noriaki Fukuhara; Shozo Yamada
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

3.  Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution.

Authors:  Ryosuke Mori; Naoko Inoshita; Junko Takahashi-Fujigasaki; Tatsuhiro Joki; Hiroshi Nishioka; Toshiaki Abe; Takeshi Fujii; Shozo Yamada
Journal:  ISRN Endocrinol       Date:  2013-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.